Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 277
Selected: 0
NCT IDTitle
NCT07335588A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
NCT06004050A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema
NCT02973776Vasoconstriction Trial With LEO 90100 Aerosol Foam
NCT01005823A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
NCT00689520Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis
NCT00263718Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris
NCT02753218A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects
NCT03549416BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
NCT01422434LEO 90105 Ointment in Japanese Subjects With Psoriasis
NCT00506519Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
NCT00764751Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris
NCT01707368Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
NCT00845481A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris
NCT01803022Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
NCT02362152The Real Life Topical Field Treatment of Actinic Keratosis Study
NCT01536938LEO 90100 in the Treatment of Psoriasis Vulgaris
NCT01083758Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
NCT03358914The PsoTeenQOL - Preliminary Reliability and Validity
NCT02518048A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris
NCT01963793Topical Aprepitant in Prurigo Patients
NCT00135863MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis
NCT05682352Investigating the Safety of LEO 158968 in Healthy Volunteers
NCT01268774Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.
NCT02627989An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids
NCT02310646Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris
NCT00958516Assessment of the Phototoxic Potential of LEO 29102 Cream
NCT02888236LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
NCT00051532Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
NCT05355818Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema
NCT03806790Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
NCT01105234An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects
NCT04306315Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight
NCT01347255A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
NCT04305327Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis
NCT03669757Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis
NCT04301362Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients
NCT03995550Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese
NCT05117060Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis
NCT05050279A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People
NCT02219633Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
NCT04533737Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab
NCT03562377Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
NCT02856542Real-life Evaluation of the Daivobet® Gel Applicator
NCT01946386A Vasoconstriction Study With LEO 90100
NCT01541553A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
NCT01701843Cromoglicate in Mastocytosis
NCT01768013The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris
NCT02549352Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
NCT03827876Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
NCT01423656Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102